DrugPatentWatch Database Preview

UNIVASC Drug Profile

« Back to Dashboard

Which patents cover Univasc, and what generic alternatives are available?

Univasc is a drug marketed by Ucb Inc and is included in one NDA.

The generic ingredient in UNIVASC is moexipril hydrochloride. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the moexipril hydrochloride profile page.

Summary for UNIVASC

US Patents:	0
Applicants:	1
NDAs:	1
Bulk Api Vendors:	31
Clinical Trials:	2
Patent Applications:	3,134
Formulation / Manufacturing:	see details
Drug Prices:	see details
DailyMed Link:	UNIVASC at DailyMed

Synonyms for UNIVASC

(3S)-2-((2S)-N-((1S)-1-Carboxy-3-phenylpropyl)alanyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid, 2-ethyl ester, monohydrochloride

(3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenyl-d5-propyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid Hydrochloride

(3S)-2-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid hydrochloride

(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid hydrochloride

(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;hydrochloride

(S)-2-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride

2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid hydrochloride

3-Isoquinolinecarboxylic acid, 1,2,3,4-tetrahydro-6,7-dimethoxy-2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-, monohydrochloride, (3S-(2(R*(R*)),3R*))-

3-isoquinolinecarboxylic acid, 1,2,3,4-tetrahydro-6,7-dimethoxy-2-(2-((1-ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-, monohydrochloride, (3S-(2(R*(R*)),3R*))-

3-Isoquinolinecarboxylic acid, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-, monohydrochloride, (3S-(2(R*(R*)),3R*))-

586M525

82586-52-5

AB2000483

AC1L1HXF

AKOS016340373

Ambap103775-10-6

AN-36120

API0003416

BS-1007

C27H34N2O7.HCl

CAS-82586-52-5

CHEBI:6961

CHEMBL1200534

CI 925

CI-925

CS-2446

CTK8G1159

D00623

DSSTox_CID_24267

DSSTox_GSID_44267

DSSTox_RID_80137

DTXSID7044267

Femipres

HY-B0378A

JXRAXHBVZQZSIC-JKVLGAQCSA-N

LS-85469

MLS003882580

Moexipril (hydrochloride)

Moexipril HCL

MOEXIPRIL HYDROCHLORIDE

Moexipril hydrochloride (USAN)

Moexipril hydrochloride [USAN]

Moexipril hydrochloride, powder, >=98% (HPLC)

Moexipril hydrochloride, United States Pharmacopeia (USP) Reference Standard

MolPort-003-666-743

NCGC00167834-01

NCGC00263546-01

Perdix

Primoxil

Q1UMG3UH45

RS 10085

RS 10085-197

RS-10085

RS-10085-197

s2079

SC-95143

SCHEMBL40877

SMR002533645

SPM 925

SPM-925

Tox21_112590

Tox21_112590_1

UNII-Q1UMG3UH45

Univasc (TN)

US Patents and Regulatory Information for UNIVASC

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ucb Inc	UNIVASC	moexipril hydrochloride	TABLET;ORAL	020312-001	Apr 19, 1995		DISCN	No	No
Ucb Inc	UNIVASC	moexipril hydrochloride	TABLET;ORAL	020312-002	Apr 19, 1995		DISCN	No	No

Expired US Patents for UNIVASC

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ucb Inc	UNIVASC	moexipril hydrochloride	TABLET;ORAL	020312-002	Apr 19, 1995
Ucb Inc	UNIVASC	moexipril hydrochloride	TABLET;ORAL	020312-002	Apr 19, 1995
Ucb Inc	UNIVASC	moexipril hydrochloride	TABLET;ORAL	020312-001	Apr 19, 1995
Ucb Inc	UNIVASC	moexipril hydrochloride	TABLET;ORAL	020312-001	Apr 19, 1995